ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹753 Cr | ₹801 Cr | ₹656 Cr | ₹657 Cr | ₹674 Cr |
What is the latest Contingent Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹753 Cr |
Mar2023 | ₹801 Cr |
Mar2022 | ₹656 Cr |
Mar2021 | ₹657 Cr |
Mar2020 | ₹674 Cr |
How is Contingent Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹753 Cr | -5.98 | |
Mar2023 | ₹801 Cr | 22.19 | |
Mar2022 | ₹656 Cr | -0.24 | |
Mar2021 | ₹657 Cr | -2.46 | |
Mar2020 | ₹674 Cr | - |
Compare Contingent Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹95,458.2 Cr | -1% | -4% | 48.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
MANKIND PHARMA | ₹102,231.0 Cr | -2.1% | -0.6% | 33.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -1% |
-4% |
48.4% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses